Philippine News Agency
Duterte still scheduled to get 2nd dose of Sinopharm
President Rodrigo Duterte received his first dose of the Sinopharm COVID-19 vaccine on May 3, administered under a Compassionate Use Permit (CSP) at the Presidential Security Group (PSG) hospital.
Despite this, Duterte apologized for receiving the Sinopharm jab before it obtained regulatory approval from the Philippine FDA.
However, Malacañang clarified that Duterte will still receive his second dose from the donated Sinopharm vaccines to complete the process.
Duterte did not experience adverse effects from the first jab and asserted his right to choose his vaccine.
He remains open to Filipinos using the Sinopharm vaccine in the future, but only if it has an emergency use authorization (EUA).
Several firms have expressed intent to apply for an EUA for the Sinopharm vaccine, but have yet to submit the necessary requirements to the FDA.
Topics in this story
Explore more stories about these topics.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.
President Rodrigo Duterte will still complete his second dose of the Sinopharm vaccine.
Read more →
Vice President Leni Robredo stated that public officials receiving COVID-19 vaccines that lack emergency use authorization (EUA) makes a mockery of the country's regulatory agencies.
Read more →
President Rodrigo Duterte expressed gratitude to Russian President Vladimir Putin and the Russian people for the donation of 15,000 doses of Sputnik V vaccines.
Read more →
Health Secretary Francisco Duque III has ordered the Department of Health (DOH) to file an emergency use authorization (EUA) application with the Food and Drug Administration for Sinopharm's COVID-19 vaccine.
+1
Read more →
Malacañang will not order the Presidential Security Group (PSG) to provide the Food and Drug Administration (FDA) with information regarding the use of unregistered COVID-19 vaccines in 2020.
Read more →